Our 2014 approach to breakthrough invasive fungal infections

Medicine and Dentistry

• Antifungal Therapy 100%
• In Vitro 50%
• Systemic Mycosis 50%
• Mycosis 50%
• Infection 50%
• Clinical Pathway 50%
• Inpatient 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Systemic Mycosis 50%
• Mycosis 50%
• Infection 50%

Immunology and Microbiology

• Breakthrough Infection 50%